STOCK TITAN
  1. Home
  2. Financials
  3. VTGN
  4. Revenue

Vistagen Therapeutics Inc (VTGN) Revenue by Year

VTGN

Vistagen Therapeutics Inc generated $1.3M in revenue in fiscal year 2026. This represents an increase of 161.1% from the prior fiscal year. Over the trailing 12 months, Q2 FY2026 through Q1 FY2027, the same line adds up to $2.5M in revenue. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters Vistagen Therapeutics Inc has filed alongside them.

FY2026 annual
Revenue $1.3M
YoY +161.1%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

VTGN Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2610-KFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-K
Revenue$2.5M$1.3M+161.1%$486K-54.3%$1.1MN/A$1.1M+1.8%$1.1M$0N/A$0-100.0%$1.3M$0N/AN/A$200K-85.1%$1.3M

TTM is the trailing twelve months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.

VTGN Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Revenue$1.5M+504.9%$464K$303K+29.5%$258K+41.0%$244K+190.5%N/A$234K-43.1%$183K-34.2%$84K-52.5%$198K+12.5%$411K+128.3%$278K

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Vistagen Therapeutics Inc financials

Frequently Asked Questions

What was Vistagen Therapeutics Inc's revenue in fiscal year 2026?

Vistagen Therapeutics Inc generated $1.3M in revenue in fiscal year 2026.

How fast is Vistagen Therapeutics Inc's revenue growing?

Vistagen Therapeutics Inc (VTGN) revenue rose by 161.1% year over year, from $486K to $1.3M in fiscal year 2026.

What is Vistagen Therapeutics Inc's revenue over the last twelve months?

Vistagen Therapeutics Inc (VTGN) reported $2.5M in revenue over the trailing 12 months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Vistagen Therapeutics Inc (VTGN) revenue went from $1.3M in fiscal year 2012 to $1.3M in fiscal year 2026.

Vistagen Therapeutics Inc (VTGN) reported $1.5M in revenue in Q1 2027. This represents an increase of 504.9% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Vistagen Therapeutics Inc (VTGN) reported on that line in every period on record.